Protease-Activated Receptor-1 antagonist 1

• UNSPSC Description:

  Protease-Activated Receptor-1 antagonist 1 (Compound 13) is a protease-activated receptor-1 (PAR-1) antagonist with the IC50 of 3 nM by FLIPR technology. Protease-Activated Receptor-1 antagonist 1 can be used for the research of thrombotic cardiovascular, myocardial infarction, and peripheral arterial disease[1].

• Target Antigen:

  Protease Activated Receptor (PAR)

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/protease-activated-receptor-1-antagonist-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [H][C@]12[C@H]([C@@H](C(F)(C[C@]1(C(O[C@@H]2C)=O)O)F)C)/C=C/C3=CC=C(C=N3)C4=CC=CC(C)=C4C#N

• Molecular Weight:

  438.47

• References & Citations:

  [1]Mihirbaran Mandal, et al. Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early Discovery. J Med Chem. 2022 Apr 14;65(7):5575-5592.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported